Showing 1 - 20 results of 37 for search 'ELIAS JABBOUR', query time: 0.03s
Refine Results
-
1
From the national system of technological innovation to the “New Projectment Economy” in China by ELIAS JABBOUR, UALLACE MOREIRA
Published 2023-08-01
Article -
2
Political Economy of the Coup d’État in Brazil by Alexis Dantas, Elias Jabbour
Published 2017-10-01
Article -
3
-
4
“O caminho chinês”: desenvolvimento desigual, projetamento e socialismo by Elias Jabbour, Vítor Boa Nova, Javier Vadell
Published 2023-12-01
Article -
5
On The Chinese Socialist Market Economy And The “New Projectment Economy” by Elias Jabbour, Alexis Dantas, Carlos José Espíndola
Published 2022-09-01
Article -
6
Development and targeted use of nilotinib in chronic myeloid leukemia by Carmen Fava, Hagop Kantarjian, Jorge Cortes, Elias Jabbour
Published 2008-11-01
Article -
7
South Korea’s and China’s catching-up: a new-developmentalist analysis by LUIZ CARLOS BRESSER-PEREIRA, ELIAS JABBOUR, LUIZ FERNANDO DE PAULA
Published 2020-04-01
Article -
8
-
9
-
10
-
11
P687: EARLY RESULTS OF A PHASE II STUDY EVALUATING THE ADDITION OF ASCIMINIB TO ERADICATE MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA by Aram Bidikian, Nicholas Short, Ramya Ganesh, Allison Pike, Koji Sasaki, Elias Jabbour, Michael Andreeff, Jorge Cortes, Ghayas Issa
Published 2023-08-01
Article -
12
P585: IMPACT OF MYELOID MUTATION PROFILE ON PCR RESPONSES AND SURVIVAL IN PATIENTS WITH CORE-BINDING FACTOR AML TREATED WITH FLAG BASED REGIMES by Jayastu Senapati, Aram Bidikian, Farhad Ravandi, Tapan Kadia, Courtney Dinardo, Guillermo Garcia-Manero, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Mark Brandt, Gautam Borthakur
Published 2023-08-01
Article -
13
P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. by Mahesh Swaminathan, Rashmi Kanagal-Shamanna, Farhad Ravandi, Tapan Kadia, Courtney Dinardo, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Sherry Pierce, John Matthew Villareal, Gautam Borthakur
Published 2023-08-01
Article -
14
P672: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND T315I MUTATION AFTER FAILURE OF PRIOR THERAPIES by Aram Bidikian, Fadi Haddad, Koji Sasaki, Ghayas Issa, Tapan Kadia, Nitin Jain, Yesid Alvarado, Nicholas Short, Musa Yilmaz, Lucia Masarova, Elias Jabbour, Hagop Kantarjian
Published 2023-08-01
Article -
15
P500: SUPERIOR OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION AMONG PATIENTS ≥ 60 YEARS TREATED WITH CLADRIBINE, LOW DOSE CYTARABINE PLUS VENETOCLAX FOR NEWLY DIAGNOSED ACUTE... by Jayastu Senapati, Hagop Kantarjian, Alexandre Bazinet, Patrick Reville, Gautam Borthakur, Naval Daver, Courtney Dinardo, Alex Bataller, Elias Jabbour, Nicholas Short, Uday R. Popat, Amin Majid Alousi, Elizabeth J. Shpall, Guillermo Garcia-Manero, Farhad Ravandi, Tapan Kadia
Published 2023-08-01
Article -
16
P358: HYPER-CVAD WITH BLINATUMOMAB AND INOTUZUMAB OZOGAMICIN FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE II STUD... by Nicholas Short, Elias Jabbour, Nitin Jain, Fadi Haddad, Musa Yilmaz, Lewis Nasr, Alessandra Ferrajoli, Tapan Kadia, Yesid Alvarado, Abhishek Maiti, Walid Macaron, Marianne Zoghbi, Cedric Nasnas, Rebecca Garris, Min Zhao, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
Published 2023-08-01
Article -
17
S172: PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE IN COMBINATION WITH VENETOCLAX IN TREATMENT-NAÏVE HIGHER-RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA by Alex Bataller, Alexandre Bazinet, Sangeetha Venugopal, Guillermo Montalban-Bravo, Yesid Alvarado, Kelly Chien, Ghayas Issa, Nicholas Short, Danielle Hammond, Lucia Masarova, Tapan Kadia, Rashmi Kanagal-Shamanna, Stephany Hendrickson, Farhad Ravandi, Elias Jabbour, Hagop Kantarjian, Guillermo Garcia-Manero
Published 2023-08-01
Article -
18
A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors... by Alejandro Zulbaran‐Rojas, Huei‐Kan Lin, Qiuling Shi, Loretta A. Williams, Binsah George, Guillermo Garcia‐Manero, Elias Jabbour, Susan O’Brien, Farhad Ravandi, William Wierda, Zeev Estrov, Gautam Borthakur, Tapan Kadia, Charles Cleeland, Jorge E. Cortes, Hagop Kantarjian
Published 2018-11-01
Article -
19
P748: IPSS-M PERFORMANCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AT THE TIME OF HYPOMETHYLATING AGENT FAILURE by Samuel Urrutia, Kelly Chien, Ziyi LI, Alex Bataller, Emmanuel Almanza, Koji Sasaki, Guillermo Montalban-Bravo, Nicholas Short, Elias Jabbour, Tapan Kadia, Farhad Ravandi, Gautam Borthakur, Rashmi Kanagal-Shamanna, Carlos Bueso Ramos, Sherry Pierce, Hagop Kantarjian, Guillermo Garcia-Manero
Published 2023-08-01
Article -
20
S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYS... by Nicholas Short, Elias Jabbour, Nitin Jain, Xuelin Huang, Walid Macaron, Lewis Nasr, Guillermo Montalban-Bravo, Tapan Kadia, Naval Daver, Kelly Chien, Yesid Alvarado, Ghayas Issa, Fadi Haddad, Cedric Nasnas, Marianne Zoghbi, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
Published 2023-08-01
Article